Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140009/S143

Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator

ABBOTT MEDICAL · Decision date Oct 27, 2026

MEDTECHLEDGER EXPLANATIONP140009/S143

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-27 for P140009/S143, a 30-Day Notice supplement to Abbott Medical's Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator. The supplement reason is listed as a process change involving a manufacturer, sterilizer, packager or supplier. The recorded statement covers a change in manufacturing of the feedthrough component used in the Implantable Pulse Generators of the Spinal Cord Stimulator and Deep Brain Stimulator systems.

This action concerns a component-level manufacturing change rather than a new approval of the Liberta RC system or of any spinal cord or deep brain stimulation device. The device category is an implanted electrical stimulator for parkinsonian tremor, specialty Neurology, product code MHY. The source record includes no documents, so the feedthrough specification, change details and any conditions of approval are not available here and remain unknown.

FDA approval order statement

approval for a change in the manufacturing of the feedthrough component utilized in the Implantable Pulse Generators (IPGs) of the Spinal Cord Stimulator and Deep Brain Stimulator systems
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 27, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140009/S143
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
OK30
Decision date
Oct 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140009 · Original PMA

    BRIO NEUROSTIMULATION SYSTEM

  2. P140009/S140 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

  3. P140009/S143 received

    Application receipt date recorded by FDA.

  4. P140009/S143 · FDA decision

    30-Day Notice

  5. P140009/S141 · Related supplement

    Deep Brain Stimulation (DBS) EPG

  6. P140009/S142 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

  7. P140009/S144 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140009

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalJun 12, 2015FDA
ABBOTT MEDICALPMA supplementSep 11, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code MHY

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Prestion Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records